In another application, SERS nanostars were used for simultaneous detection of EGFR and programmed death-ligand 1 (PD-L1) in breast cancers using multiplexed detection of EGFR- and PD-L1-targeting antibody-labeled nanotags, respectively 183. Here, EGFR is linked to breast carcinoma.